GNG Research GNG Research

SNY (SNY) Stock Analysis

SNY (SNY) is a publicly traded company in the HEALTHCARE sector. It trades at $43.50, carries a market capitalization of $105.09B, a price-to-earnings ratio of 19.00. This page summarizes the public market data, fundamentals, and frequently asked questions for SNY, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NASDAQ

Key Metrics

  • Price: $43.50
  • Market Cap: $105.09B
  • P/E Ratio: 19.00
  • EPS: $2.31
  • 52-Week High: $49.91
  • 52-Week Low: $40.89

Market Sentiment

SNY currently has a Neutral sentiment score of 0.14.

About SNY

Sanofi ADR, a leading global healthcare company headquartered in Paris, France, specializes in the research, development, manufacturing, and marketing of innovative therapeutic solutions across therapeutic areas such as specialty care, vaccines, and consumer healthcare. With a substantial pipeline of biopharmaceutical products and a presence in over 100 countries, Sanofi is well-positioned in both mature and emerging markets, addressing critical unmet medical needs. The company’s commitment t...

GNG Research Analysis

GNG Research scores SNY (SNY) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SNY.

Frequently Asked Questions

Does SNY pay dividends?

SNY (SNY) does not currently pay a regular dividend.

What is SNY's P/E ratio?

SNY has a price-to-earnings (P/E) ratio of 19.00.

What is SNY's market cap?

SNY (SNY) has a market capitalization of $105.09B with a current stock price of $43.50.